NAT10
Basic information
Region (hg38): 11:34105617-34147670
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAT10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 46 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 2 | 7 |
Variants in NAT10
This is a list of pathogenic ClinVar variants found in the NAT10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-34108232-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
11-34108262-C-T | not specified | Uncertain significance (Mar 21, 2022) | ||
11-34108314-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
11-34108767-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
11-34108810-T-C | Benign (Feb 20, 2018) | |||
11-34112124-C-T | Likely benign (Feb 20, 2018) | |||
11-34112138-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
11-34112168-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
11-34112187-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
11-34112216-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
11-34112220-G-A | Benign (Feb 20, 2018) | |||
11-34113709-C-T | Benign (Dec 31, 2019) | |||
11-34113737-A-G | Intellectual disability • not specified | Uncertain significance (Jan 26, 2022) | ||
11-34113802-C-T | Benign (Dec 31, 2019) | |||
11-34113809-T-G | not specified | Uncertain significance (Apr 08, 2024) | ||
11-34113828-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
11-34118231-G-A | Benign (Mar 30, 2018) | |||
11-34118233-T-A | not specified | Uncertain significance (May 14, 2024) | ||
11-34118265-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
11-34118274-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
11-34118293-C-T | Benign (Apr 16, 2018) | |||
11-34118408-G-C | not specified | Uncertain significance (Jan 31, 2022) | ||
11-34118415-C-G | not specified | Uncertain significance (Jul 05, 2023) | ||
11-34118418-A-T | not specified | Uncertain significance (Jan 31, 2024) | ||
11-34118443-G-C | not specified | Uncertain significance (Mar 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAT10 | protein_coding | protein_coding | ENST00000257829 | 28 | 42069 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.12e-22 | 0.598 | 125548 | 0 | 200 | 125748 | 0.000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.17 | 505 | 585 | 0.864 | 0.0000330 | 6665 |
Missense in Polyphen | 122 | 159.12 | 0.76673 | 1811 | ||
Synonymous | 2.10 | 186 | 226 | 0.823 | 0.0000125 | 2036 |
Loss of Function | 2.12 | 43 | 60.9 | 0.706 | 0.00000329 | 679 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00117 | 0.00117 |
Ashkenazi Jewish | 0.00354 | 0.00338 |
East Asian | 0.000707 | 0.000653 |
Finnish | 0.000279 | 0.000277 |
European (Non-Finnish) | 0.000717 | 0.000712 |
Middle Eastern | 0.000707 | 0.000653 |
South Asian | 0.00114 | 0.00114 |
Other | 0.000662 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: RNA cytidine acetyltransferase with specificity toward both 18S rRNA and tRNAs (PubMed:25411247, PubMed:25653167). Catalyzes the formation of N(4)-acetylcytidine (ac4C) at position 1842 in 18S rRNA (PubMed:25411247). May also catalyze the formation of ac4C at position 1337 in 18S rRNA (By similarity). Required for early nucleolar cleavages of precursor rRNA at sites A0, A1 and A2 during 18S rRNA synthesis (PubMed:25411247, PubMed:25653167). Catalyzes the formation of ac4C in serine and leucine tRNAs (By similarity). Requires the tRNA-binding adapter protein THUMBD1 for full tRNA acetyltransferase activity but not for 18S rRNA acetylation (PubMed:25653167). Can acetylate both histones and microtubules (PubMed:14592445, PubMed:17631499, PubMed:19303003). Histone acetylation may regulate transcription and mitotic chromosome de-condensation (PubMed:17631499). Activates telomerase activity by stimulating the transcription of TERT, and may also regulate telomerase function by affecting the balance of telomerase subunit assembly, disassembly, and localization (PubMed:14592445, PubMed:18082603). Acetylates alpha- tubulin, which may affect microtubule stability and cell division (PubMed:19303003). {ECO:0000250|UniProtKB:P53914, ECO:0000255|HAMAP-Rule:MF_03211, ECO:0000269|PubMed:14592445, ECO:0000269|PubMed:17631499, ECO:0000269|PubMed:18082603, ECO:0000269|PubMed:19303003, ECO:0000269|PubMed:25411247, ECO:0000269|PubMed:25653167}.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human);Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 20.02
Haploinsufficiency Scores
- pHI
- 0.153
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.934
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nat10
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- rRNA modification;negative regulation of telomere maintenance via telomerase;tRNA acetylation;rRNA acetylation involved in maturation of SSU-rRNA
- Cellular component
- nuclear chromosome, telomeric region;nucleus;nucleoplasm;telomerase holoenzyme complex;nucleolus;membrane;midbody
- Molecular function
- RNA binding;protein binding;ATP binding;N-acetyltransferase activity;DNA polymerase binding;rRNA cytidine N-acetyltransferase activity